Cargando…

Genetic Association of Olanzapine Treatment Response in Han Chinese Schizophrenia Patients

Olanzapine, a second-generation antipsychotic medication, plays a critical role in current treatment of schizophrenia (SCZ). It has been observed that the olanzapine responses in schizophrenia treatment are different across individuals. However, prediction of this individual-specific olanzapine resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wei, Xu, Yong, Lv, Qinyu, Sheng, Yong-hui, Chen, Luan, Li, Mo, Shen, Lu, Huai, Cong, Yi, Zhenghui, Cui, Donghong, Qin, Shengying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409308/ https://www.ncbi.nlm.nih.gov/pubmed/30886581 http://dx.doi.org/10.3389/fphar.2019.00177

Ejemplares similares

Novel genetic susceptibility loci identified by family based whole exome sequencing in Han Chinese schizophrenia patients
por: Li, Mo, et al.
Publicado: (2020)

Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients
por: Zhang, Xiaoqing, et al.
Publicado: (2019)

Genome-wide study of copy number variation implicates multiple novel loci for schizophrenia risk in Han Chinese family trios
por: Wu, Xi, et al.
Publicado: (2021)

Two Novel Loci of RELN Associated With Antipsychotics Response in Chinese Han Population
por: Xu, Qingqing, et al.
Publicado: (2020)

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese
por: Shen, Lu, et al.
Publicado: (2021)

Methylome-wide association study of different responses to risperidone in schizophrenia
por: Du, Huihui, et al.
Publicado: (2022)

Association of schizophrenia with the rs821633 polymorphism in the DISC1 gene among Han Chinese
por: HU, Guoqin, et al.
Publicado: (2015)

Serum trace element differences between Schizophrenia patients and controls in the Han Chinese population
por: Cai, Lei, et al.
Publicado: (2015)

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients
por: Wang, Cong, et al.
Publicado: (2018)

Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population
por: Huo, Ran, et al.
Publicado: (2012)

The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
por: Wu, Tzu-Hua, et al.
Publicado: (2021)

Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study
por: Zhao, Lei, et al.
Publicado: (2023)

Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
por: Soria-Chacartegui, Paula, et al.
Publicado: (2021)

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
por: Huang, Jing, et al.
Publicado: (2020)

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2023)

Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients
por: Shi, Y, et al.
Publicado: (2017)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Olanzapine-Induced Hyperprolactinemia: Two Case Reports
por: Barata, Pedro Cabral, et al.
Publicado: (2019)

Genetic association of the human GAP43 gene with schizophrenia in a Northeast Chinese Han population
por: Luan, Zhilin, et al.
Publicado: (2020)

Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population
por: Ding, Saidan, et al.
Publicado: (2013)

Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing
por: Tian, Junbo, et al.
Publicado: (2022)

Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
por: Zhou, Zijian, et al.
Publicado: (2023)

Functional characterization of the chlorzoxazone 6-hydroxylation activity of human cytochrome P450 2E1 allelic variants in Han Chinese
por: Wang, Ting, et al.
Publicado: (2020)

Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine
por: Huang, Piao-Piao, et al.
Publicado: (2022)

Influence of CFH gene on symptom severity of schizophrenia
por: Zhang, Chen, et al.
Publicado: (2017)

Stereopsis deficits in patients with schizophrenia in a Han Chinese population
por: Hui, Li, et al.
Publicado: (2017)

Positive Association of Human SHC3 Gene with Schizophrenia in a Northeast Chinese Han Population
por: Lv, Ye, et al.
Publicado: (2020)

Susceptibility of schizophrenia and affective disorder not associated with loci on chromosome 6q in Han Chinese population
por: Wang, Zuowei, et al.
Publicado: (2007)

Female Specific Association between NNMT Gene and Schizophrenia in a Han Chinese population
por: Wang, Guo-xia, et al.
Publicado: (2014)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
por: Xue, Hai Bo Haber, et al.
Publicado: (2014)

Association of ARHGAP18 polymorphisms with schizophrenia in the Chinese-Han population
por: Guo, Weiyun, et al.
Publicado: (2017)

ABCB1 Gene Is Associated With Clinical Response to SNRIs in a Local Chinese Han Population
por: Shan, Xiao-Xiao, et al.
Publicado: (2019)

Research in China on the molecular genetics of schizophrenia
por: Cui, Donghong, et al.
Publicado: (2012)

Erratum: Stereopsis deficits in patients with schizophrenia in a Han Chinese population
por: Hui, Li, et al.
Publicado: (2017)

Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats
por: Ashraf, Ghulam Md, et al.
Publicado: (2021)

A genetic risk factor for thrombophilia in a Han Chinese family
por: Sun, Guoping, et al.
Publicado: (2017)

A preliminary study of association of genetic variants with early response to olanzapine in schizophrenia
por: Singh, Anmol, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l0uh516s03gr2f7mgjlfvqnfca